BOSTON SCIENTIFIC CORPORATION Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-12-31 was $110.00M.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-09-30 was $1.00M, a 99.20% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $46.00M, a 88.08% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2024 was $386.00M, a 565.52% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $58.00M, a 56.06% decline from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $132.00M, a 64.32% decline from fiscal 2021.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | |||
| 2025-12-31 | $46.00M 10-K · filed 2026-02-17 | |||
| 2025-06-30 | $46.00M 10-Q · filed 2026-08-03 | |||
| 2024-12-31 | $110.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $110.00M derived: sum of 2 quarters · filed 2026-02-17 | $386.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $276.00M 10-Q · filed 2024-11-01 | ||
| 2024-06-30 | $276.00M 10-Q · filed 2025-08-01 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.00M derived: sum of 2 quarters · filed 2026-02-17 | $58.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $58.00M 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | $57.00M 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $125.00M derived: sum of 2 quarters · filed 2025-02-18 | $132.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $132.00M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $7.00M 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $197.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $325.00M derived: sum of 2 quarters · filed 2024-02-20 | $370.00M derived: sum of 3 quarters · filed 2024-02-20 | $370.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $128.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $173.00M derived: sum of 2 quarters · filed 2022-11-03 | $173.00M 10-Q · filed 2022-11-03 | $254.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $45.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $45.00M 10-Q · filed 2022-08-04 | $126.00M derived: sum of 3 quarters · filed 2023-02-23 | $345.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $81.00M derived: sum of 2 quarters · filed 2023-02-23 | $300.00M derived: sum of 3 quarters · filed 2023-02-23 | $349.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $81.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $300.00M derived: sum of 2 quarters · filed 2023-02-23 | $349.00M derived: sum of 3 quarters · filed 2023-02-23 | $533.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $219.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $268.00M derived: sum of 2 quarters · filed 2021-11-04 | $452.00M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $233.00M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $184.00M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $105.00M 10-K · filed 2022-02-23 | |||
| 2018-12-31 | $35.00M 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $4.00M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $11.00M 10-K · filed 2019-02-19 | |||
| 2015-12-31 | $19.00M 10-K · filed 2018-02-20 | |||
| 2014-12-31 | $195.00M 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $53.00M 10-K · filed 2016-02-24 | |||
| 2012-12-31 | $142.00M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | $21.00M 10-K · filed 2014-02-26 | |||
| 2010-12-31 | $65.00M 8-K · filed 2013-05-29 | |||
| 2009-12-31 | $12.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |